We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+36.45%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$13B
AUM Growth
+$2.78B
Cap. Flow
-$835M
Cap. Flow %
-6.43%
Top 10 Hldgs %
11.13%
Holding
487
New
48
Increased
80
Reduced
272
Closed
26

Top Buys

Rank Stock Value
1
RMD icon
ResMed
RMD
+$52.9M
2
WST icon
West Pharmaceutical
WST
+$39.7M
3
AMED
Amedisys
AMED
+$36.8M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$34M
5
SPOT icon
Spotify
SPOT
+$34M

Top Sells

Rank Stock Value
1
GPN icon
Global Payments
GPN
+$100M
2
CNC icon
Centene
CNC
+$90.3M
3
SBAC icon
SBA Communications
SBAC
+$56.2M
4
HXL icon
Hexcel
HXL
+$45.6M
5
EXAS
Exact Sciences
EXAS
+$44.1M

Sector Composition

Rank Sector Weight
1 Technology 25.62%
2 Healthcare 22.32%
3 Industrials 14.01%
4 Consumer Discretionary 12.64%
5 Financials 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GBCI icon
176
Glacier Bancorp
GBCI
$6.42B
$22.5M 0.17%
636,948
-89,524
-12% -$3.32M
PHM icon
177
Pultegroup
PHM
$24.1B
$22.5M 0.17%
660,448
+333,698
+102% +$10M
CFG icon
178
Citizens Financial Group
CFG
$30.3B
$22.3M 0.17%
883,400
-68,325
-7% -$1.55M
CCI icon
179
Crown Castle
CCI
$33.3B
$22.3M 0.17%
133,102
-31,612
-19% -$5.09M
ARWR icon
180
Arrowhead Research
ARWR
$11.9B
$22.2M 0.17%
513,553
– –
LLY icon
181
Eli Lilly
LLY
$1.02T
$22.2M 0.17%
135,092
-19,039
-12% -$2.92M
TGT icon
182
Target
TGT
$65.6B
$22M 0.17%
183,072
+138,572
+311% +$15.8M
ABMD
183
DELISTED
Abiomed Inc
ABMD
$21.8M 0.17%
+90,227
New +$18.1M
BRO icon
184
Brown & Brown
BRO
$23.6B
$21.6M 0.17%
529,475
-57,225
-10% -$2.21M
AMN icon
185
AMN Healthcare
AMN
$1.3B
$21.4M 0.16%
472,038
-100,100
-17% -$4.79M
KNX icon
186
Knight Transportation
KNX
$11.3B
$21.3M 0.16%
510,400
-51,450
-9% -$1.96M
JPM icon
187
JPMorgan Chase
JPM
$935B
$21.2M 0.16%
225,617
-10,283
-4% -$976K
SMPL icon
188
Simply Good Foods
SMPL
$901M
$21M 0.16%
1,130,857
+440,715
+64% +$7.81M
ZM icon
189
Zoom
ZM
$28.2B
$21M 0.16%
+82,775
New +$14.9M
BKNG icon
190
Booking.com
BKNG
$149B
$20.9M 0.16%
327,500
-83,125
-20% -$5.06M
KRTX
191
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$20.5M 0.16%
+183,606
New +$16M
KL
192
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$20.2M 0.16%
489,396
+48,700
+11% +$1.88M
KO icon
193
Coca-Cola
KO
$377B
$20.1M 0.16%
450,796
-80,548
-15% -$3.71M
ADP icon
194
Automatic Data Processing
ADP
$106B
$20M 0.15%
134,614
-6,134
-4% -$879K
FCN icon
195
FTI Consulting
FCN
$4.4B
$20M 0.15%
174,900
-38,825
-18% -$4.7M
ROKU icon
196
Roku
ROKU
$21.5B
$20M 0.15%
171,475
+14,550
+9% +$1.66M
BLDR icon
197
Builders FirstSource
BLDR
$7.15B
$19.8M 0.15%
958,288
-587,796
-38% -$10.6M
VNOM icon
198
Viper Energy
VNOM
$8.71B
$19.8M 0.15%
1,913,390
– –
HUN icon
199
Huntsman Corp
HUN
$1.71B
$19.6M 0.15%
1,091,075
-1,803,639
-62% -$30.3M
PEP icon
200
PepsiCo
PEP
$190B
$19.6M 0.15%
147,830
-6,737
-4% -$888K
6 7
8
9 10

Similar funds

GAM
Greenwoods Asset Management Grand Cayman, Cayman Islands $4.35B AUM 149.74% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
SWM
SVA Wealth Management Madison, Wisconsin $1.15B AUM 22.3% 1-Year Est. Return
LCM
Lomas Capital Management New York $1.04B AUM 24.59% 1-Year Est. Return
HCMNY
Howard Capital Management (New York) New York $891M AUM 34.82% 1-Year Est. Return
BII
Bainco International Investors Boston, Massachusetts $873M AUM 30.2% 1-Year Est. Return
HCM
Horan Capital Management Hunt Valley, Maryland $794M AUM 30.86% 1-Year Est. Return
DBC
Deep Basin Capital Stamford, Connecticut $739M AUM 4.75% 1-Year Est. Return

Carillon Tower Advisers's Q2 2020 Portfolio in Review

As of Q2 2020, Carillon Tower Advisers held 487 positions worth $13B, up 27% from $10.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Carillon Tower Advisers withdrew a net $835M in Q2 2020, closing 26 positions and reducing 272 holdings. Its most notable exit was Exact Sciences, an estimated $44.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Carillon Tower Advisers opened a new position in ResMed worth $62M.

  • Carillon Tower Advisers's largest Q2 2020 buy was ResMed: 323,155 shares worth $62M.
  • Carillon Tower Advisers added most to Amedisys in Q2 2020, an estimated $36.8M increase.
  • Carillon Tower Advisers's biggest Q2 2020 reduction was Global Payments, cutting an estimated $100M.
  • Carillon Tower Advisers fully exited Exact Sciences in Q2 2020, selling an estimated $44.1M.
  • Carillon Tower Advisers's ten largest holdings make up 11% of its $13B portfolio in Q2 2020.
  • Carillon Tower Advisers opened 48 new positions and closed 26 in Q2 2020.
  • Carillon Tower Advisers's portfolio value rose 27% quarter-over-quarter to $13B.

Based on Carillon Tower Advisers's 13F filing for Q2 2020, filed 12 Aug 2020.